Search by Drug Name or NDC

    NDC 50844-0261-08 Naproxen 220 mg/1 Details

    Naproxen 220 mg/1

    Naproxen is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by L.N.K. International, Inc.. The primary component is NAPROXEN SODIUM.

    Product Information

    NDC 50844-0261
    Product ID 50844-261_dc9e496e-cb8c-44f1-9fe0-beceaed8d9be
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Naproxen
    Proprietary Name Suffix n/a
    Non-Proprietary Name Naproxen Sodium
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 220
    Active Ingredient Units mg/1
    Substance Name NAPROXEN SODIUM
    Labeler Name L.N.K. International, Inc.
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204872
    Listing Certified Through 2024-12-31

    Package

    NDC 50844-0261-08 (50844026108)

    NDC Package Code 50844-261-08
    Billing NDC 50844026108
    Package 1 BOTTLE, PLASTIC in 1 CARTON (50844-261-08) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
    Marketing Start Date 2019-08-06
    NDC Exclude Flag N
    Pricing Information N/A